3 December, 2019
Our scientific advisor, Dr. Priscila Kosaka, was awarded for her research in the oncology field
Our scientific advisor, Dr. Priscila Kosaka, was awarded by Fundación Fero for her research projects…
Read More
Mecwins technology is based on a combination of nanomechanical sensing and plasmonic emission with a sandwich immunoassay. The detection limit achieved with our technology is at least one million lower than that achieved in routine clinical practice.
Scientific Instrumentation
Mecwins offers an optical platform for MEMS characterization using its proprietary technology. This technique has been implemented in a robust instrument, named SCALA, a complete tool to characterize your devices in air, liquid and vacuum environments.
Mission
We think high. Together with our in-house expertise, Mecwins applies the latest advancements of Nanotechnology in the Sensors field with the mission of helping scientists and physicians to reach the unbelievable
People
Mecwins team is comprised of experienced scientists and technicians. We aim to combine knowledge and expertise from different fields to provide innovative tools for research and analysis in life sciences. 50% of our team has a PhD degree.
Patents
The World Intellectual Property Organization (WIPO) protects our technology and our innovative method to detect biomolecules. Mecwins possesses exclusive licenses for several patents, since the technology thereby protected is usable in many applications, from microelectronics to biomedicine.
Main Investors
Since our establishment in 2008, we have forged strong relationships with several investors focus on the long-term value creation. They are the heart of our business and together with our scientific promoters (Dr. Javier Tamayo, Dr. Montserrat Calleja and Dr. Priscila Kosaka) help Mecwins to achieve its ambitious goals.
News and Events
Scientific developments never stop and neither can we. Explore the latest news and recent events in the world of Mecwins.
16 August, 2019
Mecwins IVD4Sepsis project has been selected for publication in the ‘Results in Brief’ section of the European Commission’s CORDIS website
Mecwins IVD4Sepsis project has been selected for publication in the ‘Results in Brief’ section of…
Read More
5 July, 2019
New publication in collaboration with UAM
A new paper from our scientific staff and researchers from the Autonomous University of Madrid…
Read More
Proyecto "SPECTRASENS": Financiado por: FEDER/Ministerio de Ciencia, Innovación y Universidades – Agencia Estatal de Investigación/ _Proyecto RTC-2017-6311-1.
